课题基金 / 基金详情

Assessment of SARS-Coronavirus-2 Levels and Genetics in Vivo

Assessment of SARS-Coronavirus-2 Levels and Genetics in Vivo
体内 SARS-Coronavirus-2 水平和遗传学评估
批准号:
10262598
负责人:
Mary Kearney
金额:
$28.27万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Mary Kearney的其他基金

相似基金

相关文献

中文摘要
翻译
到目前为止,我们已经从匹兹堡大学医学中心的10名患者那里获得了全血、血浆和外周血单核细胞。与匹兹堡大学的研究人员合作,包括约翰·梅勒斯博士和贾娜·雅各布斯博士,我们在大多数样本中检测到CoV-2RNA。所有感染样本都在匹兹堡大学接受检测,我们打算只在NCI-Frederick接受裂解的非感染样本。在未来的实验中,我们打算评估纵向样本,以调查患者中CoV-2 RNA血症的动力学。我们还将对患者样本中的病毒进行测序,以确定是否有任何特定的突变可能与更高水平的病毒血症有关。
英文摘要
To date, we have received whole blood, plasma, and peripheral blood mononuclear cells from 10 patients at the University of Pittsburgh Medical Center. In collaboration with investigators at the University of Pittsburgh, including Drs. John Mellors and Jana Jacobs, we have detected CoV-2 RNA in the majority of samples. All infectious samples are being tested at the University of Pittsburgh and we intend to receive only lysed, noninfectious samples at NCI-Frederick. In future experiments, we intend to evaluate longitudinal samples to investigate the dynamics of CoV-2 RNAemia in patients. We will also sequence the virus in the patient samples to determine if there are any specific mutations that may be associated with higher levels of viremia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterizing HIV-1 diversity, evolution, and integration sites in children initiating cART in early infection
  • 批准号:
    9057998
  • 项目类别:
  • 资助金额:
    $16.98万
  • 财政年份:
    2015
  • 负责人:
    Mary Kearney
  • 依托单位:
Characterizing HIV-1 diversity, evolution, and integration sites in children initiating cART in early infection
  • 批准号:
    9477520
  • 项目类别:
  • 资助金额:
    $16.71万
  • 财政年份:
    2015
  • 负责人:
    Mary Kearney
  • 依托单位:
Dynamics and Genetics of HIV Proviruses before and during Antiretroviral Therapy
  • 批准号:
    10702615
  • 项目类别:
  • 资助金额:
    $114.57万
  • 财政年份:
    --
  • 负责人:
    Mary Kearney
  • 依托单位:
Impact of Interventions on Clonally Expanded Proviruses and Their RNA Expression
海外基金